- Chemoprevention for Barrett's esophagus trial. Design and outcome measuresE I Heath
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, USA
Dis Esophagus 16:177-86. 2003..Secondary outcomes include change from baseline in the maximal grade, extent and surface area of dysplasia. Tertiary outcomes will include measurements of various relevant biomarkers...